These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. INI1 mutations in meningiomas at a potential hotspot in exon 9. Schmitz U; Mueller W; Weber M; Sévenet N; Delattre O; von Deimling A Br J Cancer; 2001 Jan; 84(2):199-201. PubMed ID: 11161377 [TBL] [Abstract][Full Text] [Related]
3. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635 [TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of hSNF5/INI1 and TP53 genes in choroid plexus carcinomas. Zakrzewska M; Wojcik I; Zakrzewski K; Polis L; Grajkowska W; Roszkowski M; Augelli BJ; Liberski PP; Rieske P Cancer Genet Cytogenet; 2005 Jan; 156(2):179-82. PubMed ID: 15642401 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283 [TBL] [Abstract][Full Text] [Related]
6. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049 [TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation. Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100 [TBL] [Abstract][Full Text] [Related]
8. Secondary meningioma in a long-term survivor of atypical teratoid/rhabdoid tumour with a germline INI1 mutation. Ammerlaan AC; Houben MP; Tijssen CC; Wesseling P; Hulsebos TJ Childs Nerv Syst; 2008 Jul; 24(7):855-7. PubMed ID: 18236049 [TBL] [Abstract][Full Text] [Related]
9. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540 [TBL] [Abstract][Full Text] [Related]
10. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors. Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529 [TBL] [Abstract][Full Text] [Related]
11. Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene. Kraus JA; Oster C; Sörensen N; Berthold F; Schlegel U; Tonn JC; Wiestler OD; Pietsch T Neuropathol Appl Neurobiol; 2002 Apr; 28(2):136-41. PubMed ID: 11972800 [TBL] [Abstract][Full Text] [Related]
12. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules. Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829 [TBL] [Abstract][Full Text] [Related]
13. Absence of hSNF5/INI1 mutation in human lung cancer. Manda R; Kohno T; Hamada K; Takenoshita S; Kuwano H; Yokota J Cancer Lett; 2000 May; 153(1-2):57-61. PubMed ID: 10779630 [TBL] [Abstract][Full Text] [Related]
14. Heterozygosity loss at 22q and lack of INI1 gene mutation in gastrointestinal stromal tumor. Yamamoto H; Kohashi K; Tsuneyoshi M; Oda Y Pathobiology; 2011; 78(3):132-9. PubMed ID: 21613800 [TBL] [Abstract][Full Text] [Related]
15. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046 [TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of INI1 in sporadic human brain tumors. Weber M; Stockhammer F; Schmitz U; von Deimling A Acta Neuropathol; 2001 May; 101(5):479-82. PubMed ID: 11484819 [TBL] [Abstract][Full Text] [Related]
17. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258 [TBL] [Abstract][Full Text] [Related]
18. The mouse ortholog of the human SMARCB1 gene encodes two splice forms. Bruder CE; Dumanski JP; Kedra D Biochem Biophys Res Commun; 1999 Apr; 257(3):886-90. PubMed ID: 10208879 [TBL] [Abstract][Full Text] [Related]
19. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Izumi T; Oda Y; Yamamoto H; Tamiya S; Taguchi T; Iwamoto Y; Hasegawa T; Tsuneyoshi M Hum Pathol; 2009 Mar; 40(3):349-55. PubMed ID: 18973917 [TBL] [Abstract][Full Text] [Related]
20. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Ammerlaan AC; Ararou A; Houben MP; Baas F; Tijssen CC; Teepen JL; Wesseling P; Hulsebos TJ Br J Cancer; 2008 Jan; 98(2):474-9. PubMed ID: 18087273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]